miR-31 controls late muscle differentiation by inhibiting dystrophin translation and is up-regulated in dystrophic skeletal muscles.12 The discrepancy between skeletal and myocardial miR-31 expression is unclear and poses the question of the potential cellular sources of miR-31 in human AF. This evidence concerns the gene DMD and atrial fibrillation.